SCHEMBL7270089

SCHEMBL7270089

[Li]c1ccc(OCOC)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO1 P15559 1/20 0.40
▸ MMP2 P08253 1/20 0.38
▸ MMP3 P08254 1/20 0.38
▸ MMP9 P14780 1/20 0.38
▸ MMP14 P50281 1/20 0.38
▸ FYN P06241 4/20 0.35
▸ BACE1 P56817 1/20 0.35
▸ TSHR P16473 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ MAPT P10636 1/20 0.32
▸ KDR P35968 1/20 0.32
▸ APP P05067 3/20 0.31
▸ FFAR1 O14842 1/20 0.31
▸ LTA4H P09960 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3589633 0.87 NQO1 (0.50) NQO1MMP2MMP3MMP9MMP14
SCHEMBL14514637 0.80 CA1 (0.58) TSHRTDP1CA12CA1CA2
SCHEMBL197283 0.80 FYN (0.45) NQO1MMP2MMP3MMP9MMP14
SCHEMBL12926336 0.80 MMP2 (0.51) NQO1MMP2MMP3MMP9MMP14
SCHEMBL2131789 0.78 ACHE (0.52) NQO1MAPT
SCHEMBL8955232 0.77 NQO1 (0.37) NQO1MMP2MMP3MMP9MMP14
SCHEMBL17553700 0.76 NQO1 (0.40) NQO1MMP2MMP3MMP9MMP14
SCHEMBL12772054 0.76 CYP1A2 (0.46) TDP1APP
SCHEMBL1923910 0.76 LTA4H (0.54) APPLTA4H
SCHEMBL13170580 0.76 APP (0.48) NQO1MMP2MMP3MMP9MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0402646-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 1998-07-22 — — EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 — — EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 — — US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 — — US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 — — US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 — — EP disclosed
Send feedback